{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:36Z","timestamp":1777870416632,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000042","name":"Amgen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40620-018-0527-x","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T20:09:51Z","timestamp":1535486991000},"page":"767-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results"],"prefix":"10.1093","volume":"31","author":[{"name":"The Italian Study Group on Mineral Metabolism","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3071-1893","authenticated-orcid":false,"given":"Sandro","family":"Mazzaferro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Cascone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Di Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Pani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Morosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Nordio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Martello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"527_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ki.2012.69","volume":"82","author":"PA Torres","year":"2012","unstructured":"Torres PA, De Broe M (2012) Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 82:19\u201325","journal-title":"Kidney Int"},{"issue":"3","key":"527_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfv020","volume":"30","author":"J Bover","year":"2015","unstructured":"Bover J, Evenepoel P, Urena-Torres P, on behalf of the CKD-MBD Working group of ERA-EDTA et al (2015) Pro: Cardiovascular calcifications are clinically relevant. Nephrol Dial Transplant 30(3):345\u2013351","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"527_CR3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15(7):1943\u20131951","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"527_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","volume":"30","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Fukagawa M (2017) Uremic toxicity and bone in CKD. J Nephrol 30(5):623\u2013627","journal-title":"J Nephrol"},{"issue":"5","key":"527_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40620-017-0410-1","volume":"30","author":"L Tartaglione","year":"2017","unstructured":"Tartaglione L, Pasquali M, Rotondi S, Muci ML, Covic A, Mazzaferro S (2017) Positioning novel biologicals in CKD-mineral and bone disorders. J Nephrol 30(5):689\u2013699","journal-title":"J Nephrol"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519\u2013530","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"527_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.semnephrol.2014.09.006","volume":"34","author":"S Mazzaferro","year":"2014","unstructured":"Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M (2014) News on biomarkers in CKD-MBD. Semin Nephrol 34(6):598\u2013611","journal-title":"Semin Nephrol"},{"key":"527_CR8","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"527_CR9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fern\u00e1ndez-Mart\u00edn","year":"2015","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Mart\u00ednez-Camblor P, Dionisi MP, COSMOS group et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542\u20131551","journal-title":"Nephrol Dial Transplant"},{"issue":"02","key":"527_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5301\/JN.2010.6193","volume":"24","author":"S Mazzaferro","year":"2011","unstructured":"Mazzaferro S, Brancaccio D, MessaP,et al on behalf of the FARO Study Group (2011) Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey. J Nephrol 24(02):225\u2013235","journal-title":"J Nephrol"},{"issue":"1","key":"527_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40620-015-0202-4","volume":"29","author":"M Gallieni","year":"2016","unstructured":"Gallieni M, De Luca N, Santoro D et al (2016) Management of CKD-MBD in non-dialysispatients under regular nephrology care: a prospectivemulticenterstudy. J Nephrol 29(1):71\u201378","journal-title":"J Nephrol"},{"issue":"6","key":"527_CR12","first-page":"1","volume":"31","author":"M Minuto","year":"2014","unstructured":"Minuto M, Vera L, Ansaldo GL et al (2014) Modernapproach to parathyroidectomy. G Ital Nefrol 31(6):1\u201318","journal-title":"G Ital Nefrol"},{"issue":"7","key":"527_CR13","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1093\/ndt\/gfm931","volume":"23","author":"S Mazzaferro","year":"2008","unstructured":"Mazzaferro S, Pasquali M, Farcomeni A et al (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K\/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23(7):2319\u20132323","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"527_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00423-011-0901-9","volume":"397","author":"Bojan Kovacevic","year":"2012","unstructured":"Kovacevic B, Ignjatovic M, Zivaljevic V et al (2012) Parathyroidectomy for the attainment of NKF-K\/DOQI\u2122 and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism.Langenbecks Arch Surg. 397(3):413\u2013420","journal-title":"Langenbeck's Archives of Surgery"},{"issue":"1","key":"527_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12893-016-0193-7","volume":"16","author":"JB Wetmore","year":"2016","unstructured":"Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ (2016) Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis. BMC Surg 16(1):77","journal-title":"BMC Surg"},{"issue":"5","key":"527_CR16","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","volume":"66","author":"B Kestenbaum","year":"2004","unstructured":"Kestenbaum B, Andress DL, Schwartz SM et al (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66(5):2010\u20132016","journal-title":"Kidney Int"},{"issue":"12","key":"527_CR17","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/ndt\/gfv334","volume":"30","author":"KM Ivarsson","year":"2015","unstructured":"Ivarsson KM, Akaberi S, Isaksson E et al (2015) The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant 30(12):2027\u20132033","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"527_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/ki.2015.123","volume":"88","author":"JJ Scialla","year":"2015","unstructured":"Scialla JJ, WolfM (2015) When there will never be a randomized controlled trial. Kidney Int 88(2):220\u2013222","journal-title":"Kidney Int"},{"issue":"6","key":"527_CR19","first-page":"1242","volume":"12","author":"F Malberti","year":"2001","unstructured":"Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am SocNephrol 12(6):1242\u20131248","journal-title":"J Am SocNephrol"},{"issue":"suppl 3","key":"527_CR20","first-page":"s1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(suppl 3):s1\u2013s201","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"527_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0962280206079046","volume":"17","author":"A Farcomeni","year":"2008","unstructured":"Farcomeni A (2008) A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion. Stat Methods Med Res 17(4):347\u2013388","journal-title":"Stat Methods Med Res"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1523-1755.2004.00368.x","volume":"65","author":"B Kestembaum","year":"2004","unstructured":"Kestembaum B, Selinger SL, Gillen DL et al (2004) Parathyroidectomy rates among United States dialysis patients:1990\u20131999. Kidney Int 65:282\u2013288","journal-title":"Kidney Int"},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2369-15-75","volume":"15","author":"S Akaberi","year":"2014","unstructured":"Akaberi S, Clyne N, Sterner G et al (2014) Temporal trends and risk factors for parathyroidectomy in the Swedish dialysis and transplant population\u2014a nationwide, population-based study 1991\u20132009. BMC Nephrol 15:75","journal-title":"BMC Nephrol"},{"issue":"S113","key":"527_CR24","first-page":"S1","volume":"76","author":"Kidney Disease: Improving Global Outcomes CKDMBDWG","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 76(S113):S1\u2013S130","journal-title":"Kidney Int Suppl"},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"issue":"12","key":"527_CR26","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1210\/jc.2013-2975","volume":"98","author":"PS Parfrey","year":"2013","unstructured":"Parfrey PS, Chertow GM, Block GA et al (2013) The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab 98(12):4834\u20134844","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"527_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40620-018-0481-7","volume":"31","author":"A Bellasi","year":"2018","unstructured":"Bellasi A, Morrone L, Mereu MC et al (2018) working group on CKD-MBD of the Italian Society of Nephrology. CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy. J Nephrol 31(4):585\u2013591","journal-title":"J Nephrol"},{"key":"527_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1681\/ASN.V112330","volume":"11","author":"A upta","year":"2000","unstructured":"upta A, Kallanbach LR, Zasuwa G et al (2000) Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 11:330\u2013334","journal-title":"J Am Soc Nephrol"},{"key":"527_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","volume":"126","author":"RA Wermers","year":"1997","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O\u2019Fallon WM, Meltron LJ (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992. Ann Intern Med 126:433\u2013440","journal-title":"Ann Intern Med"},{"key":"527_CR30","first-page":"s62","volume":"Suppl38","author":"HH Malluche","year":"1992","unstructured":"Malluche HH, Monier-Faugere MC (1992) Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl38:s62\u201367","journal-title":"Kidney Int"},{"issue":"2","key":"527_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/qjmed\/hcu170","volume":"108","author":"S Bell","year":"2015","unstructured":"Bell S, Fletcher EH, Brady I, Looker HC, Levin D, Joss N et al (2015) End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM 108(2):127\u2013134","journal-title":"QJM"},{"key":"527_CR32","doi-asserted-by":"publisher","first-page":"s161","DOI":"10.1053\/ajkd.2001.27428","volume":"38","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Ozono K, Miyauchi A et al (2001) Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Int 38:s161\u20134","journal-title":"Am J Kidney Int"},{"key":"527_CR33","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","volume":"20","author":"Y Iwasaki-Ishizuka","year":"2005","unstructured":"Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T et al (2005) Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 20:1904\u20131911","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"527_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Dr\u00fceke","year":"2016","unstructured":"Dr\u00fceke TB, Massy ZA (2016 Feb) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89(2):289\u2013302","journal-title":"Kidney Int"},{"issue":"5","key":"527_CR35","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA Oliveira de","year":"2015","unstructured":"de Oliveira RA, Barreto FC, Mendes M et al (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87(5):1039\u20131045","journal-title":"Kidney Int"},{"key":"527_CR36","first-page":"67","volume":"21","author":"S Sato","year":"1995","unstructured":"Sato S, Ohta M, Kawaguchi Y et al (1995) Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 21:67\u201371","journal-title":"Miner Electrolyte Metab"},{"issue":"5","key":"527_CR37","doi-asserted-by":"publisher","first-page":"M901","DOI":"10.1097\/00002480-199609000-00123","volume":"42","author":"R Rault","year":"1996","unstructured":"Rault R, Magnone M (1996) The effect of parathyroidectomy on hematocrit and erythropoietin dose in patients on hemodialysis. ASAIO J (Am Soc Artif Intern Organs 1992) 42(5):M901\u2013M903","journal-title":"ASAIO J (Am Soc Artif Intern Organs 1992)"},{"issue":"4","key":"527_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0002-9610(99)00194-4","volume":"178","author":"C Yasunaga","year":"1999","unstructured":"Yasunaga C, Nakamoto M, Matsuo K, Nishihara G, Yoshida T, Goya T (1999) Effects of aparathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism. Am J Surg 178(4):332\u2013336","journal-title":"Am J Surg"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:39Z","timestamp":1777564659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/31\/5\/767\/8371447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0527-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SM received honoraria for Congress presentations by Vifor Fresenius; LT, CC, NDD, AP, MM, MF, MN, ML, MM, CG, SR and MP declare no\n                      CoI\n                      . MC gave lectures for Amgen, Abbvie, Shire, Vifor Fresenius, Baxter.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on welfare of animals"}}]}}